Newest Drugs for Chronic Unexplained Nausea and Vomiting.

about

The Role and Treatment Implications of Peripheral and Central Processing of Pain, Pruritus, and Nausea in Heightened Somatic Awareness: A Review.A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research

P2860

Q42360911-B6864722-A699-43C3-BDB4-79BB4CC9B18F Q57161235-3695261B-6D95-4E1C-BBEC-5FC2D985A86B

P2860

Newest Drugs for Chronic Unexplained Nausea and Vomiting.

Item

http://www.wikidata.org/entity/Q38977503

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Newest Drugs for Chronic Unexplained Nausea and Vomiting.

@en

type

Item

label

Newest Drugs for Chronic Unexplained Nausea and Vomiting.

@en

prefLabel

Newest Drugs for Chronic Unexplained Nausea and Vomiting.

@en

P1476

Newest Drugs for Chronic Unexplained Nausea and Vomiting.

@en

P2093

William L Hasler

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation

Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant-palonosetron combination

Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment

Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program.

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.

Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine.

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy.

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy.

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.

Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial

P2888

s11938-016-0110-2

P304

371-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11938-016-0110-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27726068

http://www.w3.org/2001/XMLSchema#string

P932

5814321

http://www.w3.org/2001/XMLSchema#string

Newest Drugs for Chronic Unexplained Nausea and Vomiting.

about

P2860

P2860

Newest Drugs for Chronic Unexplained Nausea and Vomiting.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932